Atipamezole
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 4-(2-Ethyl-1,3-dihydroinden-2-yl)-3H-imidazole | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | Veterinary use only |
| Identifiers | |
| CAS number | 104054-27-5 |
| ATCvet code | QV03AB90 |
| PubChem | CID 71310 |
| UNII | 03N9U5JAF6  |
| KEGG | D03002 |
| Chemical data | |
| Formula | C14H16N2 |
| Mol. mass | 212.290 g/mol |
 (what is this?) (verify) |
Atipamezole (brand name Antisedan, Pfizer) is a synthetic alpha2-adrenergic antagonist, indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.[1] It has also been researched in humans as a potential anti-Parkinsonian drug.[2]
[edit] References
- ^ Pfizer Animal Health ANTISEDAN Product Overview
- ^ Pertovaara A, Haapalinna A, Sirviö J, Virtanen R (2005). "Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist". CNS Drug Reviews 11 (3): 273–88. doi:10.1111/j.1527-3458.2005.tb00047.x. PMID 16389294.
[edit] External links
 |
This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it. |
